Sappe Public Company Limited (SAPPE)
Thailand Exchange · Thailand · prices in THB · close of 22 Oct 2026
Key indicators
| Last close | THB 30.50 |
|---|---|
| 52-week range | 28.50 – 38.25 |
| Return, 1 month / 3 months | −5.4% / −7.6% |
| Return, 1 year / 3 years | −10.9% / −56.2% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 32.7% |
| Worst drawdown (1 year) | -25.0% |
| Average daily value traded | 10.09M THB |
| Dividend yield | 5.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sappe Public Company Limited is a Thai beverage maker based in Thailand that develops, produces and markets ready-to-drink drinks. Its range includes fruit juices, drinking yoghurt and functional beverages sold under brands such as Sappe Beauti Drink, aimed at consumers who want convenient everyday drinks. The company sells through convenience stores, supermarkets and other retail outlets in its home market and also exports its products to customers in several overseas countries.
The shares are listed on the Thailand Exchange in Thailand under the code SAPPE, and the price on this page is in Thai baht (THB). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sappe Public Company Limited (SAPPE) trades on the Thailand Exchange in Thailand. It last closed at THB 30.50 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 644 of 1,349 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.9% and over the last three months it fell 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.1% | ||
| From 52-week high | -19.7% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.6% | ||
| 6-month return | 4.2% | ||
| 12-month return, skipping the last month | -5.8% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.0% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 10.09M THB | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | −5.4% |
| 3 months | −7.6% |
| 6 months | +4.2% |
| 1 year | −10.9% |
| 3 years | −56.2% |
| 5 years | +46.4% |
Signals
| 50-day / 200-day average | 32.92 / 31.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2026 | THB 1.7500 |
| 22 Apr 2025 | THB 2.2500 |
| 24 Apr 2024 | THB 2.1800 |
| 9 May 2023 | THB 1.6500 |
| 6 May 2022 | THB 1.1000 |
| 10 May 2021 | THB 1.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.